Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.
Aspirin is widely used for prevention of cardiovascular disease. In recent years randomized trials also suggested a preventive effect for various types of cancer. We aimed to assess, in a quantitative way, benefits and harms of aspirin for primary prevention of both cardiovascular disease and cancer...
Main Authors: | Inge Stegeman, Patrick M Bossuyt, Tsung Yu, Cynthia Boyd, Milo A Puhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4494891?pdf=render |
Similar Items
-
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
by: Henock G. Yebyo, et al.
Published: (2019-09-01) -
Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01) -
Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01) -
Aspirin Use for Primary Prevention of Cardiovascular Disease
by: Frauenberg, Sarah
Published: (2019) -
Aspirin overutilization for the primary prevention of cardiovascular disease
by: VanWormer JJ, et al.
Published: (2014-12-01)